Samuel Bernstein ’08

Samuel C. Bernstein has been elected partner at McGuireWoods, effective January 1, 2019. He represents pharmaceutical and medical device companies regarding FDA approval pathways, fraud and abuse issues, off-label promotion, adverse event reporting, developing and implementing compliance programs, and other regulatory and compliance matters.